logo

AB Science

ab-science.com

Details:
Details about AB Science

AB Science is currently developing two main compounds, masitinib, a highly selective tyrosine kinase inhibitor and AB8939.



Employees:
Employees at AB Science
VP Clinical Operations at AB Science

Senior Clinical Data Manager at AB Science

Senior Study Manager at AB Science

Product Lead - Therapies for Immune and Inflammatory Diseases at AB Science

AB Science

Clinical Project Manager Associate at AB Science

Non clinical and Clinical Project Manager at AB Science

Head of Pharmaceutical Development and CMC and Pharmaceutical Operations at AB Science

Senior Finance Manager - Forecasting, Revenue and Cost of Energy at AB Science

Responsable R and D at AB Science

Principal Statistical Programmer at AB Science

Head Of Quality Assurance at AB Science

Chef de Projet Clinique at AB Science

AB Science